or
forgot password

    • cancer clinical trials in lebanon, NH

    • ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
    Dartmouth Medical School
    Lebanon, New Hampshire 03756
    Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension
    Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer
    Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire 03756
    Non-small Cell Lung Cancer
    Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme
    Darthmouth -Hitchcock Medical Center
    Lebanon, New Hampshire 03756
    Glioblastoma Multiforme
    Collecting and Storing Tissue Samples From Patients With Head and Neck Cancer
    Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire 03756-0002
    Head and Neck Cancer
    A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma
    Dartmouth Medical School
    Lebanon, New Hampshire 03756
    Adrenocortical Carcinoma
    Protocol to Distinguish Tumor Recurrence From Treatment-Related Necrosis in Patients With High Grade Gliomas
    Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire 03756
    Recurrent High Grade Gliomas
    A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors
    Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center
    Lebanon, New Hampshire 03756
    Advanced Solid Tumors
    Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF
    Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire 03756
    Non-Hodgkin's Lymphoma, Hodgkin's Disease, Multiple Myeloma, Other Plasma Cell Dyscrasia (Waldenstrom, Amyloidosis), Leukemia
    Partner Assistance in Learning and Performing Skin Self-Examination
    Dartmouth Hitchcock Medical Center
    Lebanon, New Hampshire 03756
    Melanoma
    Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease
    Dartmouth Hitchcock Medical Center
    Lebanon, New Hampshire 03756
    Hemangioblastomas, Von Hippel Lindau Disease
    Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer
    1230.2.19 Boehringer Ingelheim Investigational Site
    Lebanon, New Hampshire
    Neoplasms
    Third Eye Retroscope Randomized Clinical Evaluation
    Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire 03756
    Colorectal Neoplasms
    Protocol to Obtain Blood for Discovery of Novel Biomarkers and Potential Therapeutic Targets in Chronic Lymphocytic Leukemia
    Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire 03756
    Chronic Lymphocytic Leukemia
    A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869)
    Site Reference ID/Investigator# 36527
    Lebanon, New Hampshire 03756-0001
    Solid Tumors
    Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
    Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire 03756
    Crohn's Disease
    Vitamin D and Breast Cancer Biomarkers in Female Patients
    Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire 03756-0002
    Breast Cancer
    Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Dartmouth Hitchcock Medical Center
    Lebanon, New Hampshire 03756
    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
    Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire 03756
    Metastatic Pancreatic Cancer
    Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
    Dartmouth Hitchcock Medical Center
    Lebanon, New Hampshire 03756
    Anemia, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small-Cell Lung, Bladder Cancer, Cancer of Head and Neck, Uterine Cervical Cancer
    A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma
    Mary Hitchcock Memorial Hospital, NH
    Lebanon, New Hampshire
    Renal Cell Carcinoma
    A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
    Dartmouth Hitchcock Medical Center - Section of Dermatology
    Lebanon, New Hampshire 03756
    Psoriasis
    An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors
    Site Reference ID/Investigator# 53004
    Lebanon, New Hampshire 03756-0001
    Advanced Solid Tumors
    Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin
    Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center
    Lebanon, New Hampshire 03756
    Renal Cell Carcinoma, Hepatocellular Carcinoma, Colorectal Carcinoma
    A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer
    Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire 03756
    Lung Cancer in Normal and Malignant Tumors
    Patient Derived Breast Cancer Xenografts
    Dartmouth Hitchcock Medical Center
    Lebanon, New Hampshire 03756
    Metastatic Breast Cancer
    Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma.
    Dartmouth Hitchcock Medical Center Dept Onc
    Lebanon, New Hampshire 03756
    Locally Advanced or Metastatic BRAF Mutant Melanoma
    Developing Plasma DNA as a Surrogate for Tumor Biopsy to Identify Tumor Genetic Alterations in Patients With Advanced Breast Cancer
    Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire 03756
    Advanced Breast Cancer
    Phase I/II Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered Subcutaneously in Patients With B-cell NHL
    Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire 03756
    B-cell Non-Hodgkin Lymphoma
    Biological Therapy With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
    Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire 03756
    Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer